Betta Pharmaceuticals Co Ltd
SZSE:300558
Wall Street
Price Targets
Price Targets Summary
Betta Pharmaceuticals Co Ltd
According to Wall Street analysts, the average 1-year price target for Betta Pharmaceuticals Co Ltd is 59.03 CNY with a low forecast of 45 CNY and a high forecast of 72.53 CNY.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Betta Pharmaceuticals Co Ltd
For the last 8 years the compound annual growth rate for Betta Pharmaceuticals Co Ltd's operating income is -1%. The projected CAGR for the next 3 years is 61%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Betta Pharmaceuticals Co Ltd's stock price target?
Price Target
59.03
CNY
According to Wall Street analysts, the average 1-year price target for Betta Pharmaceuticals Co Ltd is 59.03 CNY with a low forecast of 45 CNY and a high forecast of 72.53 CNY.
What is Betta Pharmaceuticals Co Ltd's Revenue forecast?
Projected CAGR
25%
For the last 8 years the compound annual growth rate for Betta Pharmaceuticals Co Ltd's revenue is 13%. The projected CAGR for the next 3 years is 25%.
What is Betta Pharmaceuticals Co Ltd's Operating Income forecast?
Projected CAGR
61%
For the last 8 years the compound annual growth rate for Betta Pharmaceuticals Co Ltd's operating income is -1%. The projected CAGR for the next 3 years is 61%.
What is Betta Pharmaceuticals Co Ltd's Net Income forecast?
Projected CAGR
46%
For the last 8 years the compound annual growth rate for Betta Pharmaceuticals Co Ltd's net income is 0%. The projected CAGR for the next 3 years is 46%.
You don't have any saved screeners yet
